4925 Results

People

  1. Giralt
    Giralt
  2. Berger
    Berger
  3. Morrow
    Morrow
  4. Horwitz
    Horwitz
  5. Ladanyi
    Ladanyi
  6. Lee
    Lee
  7. Adusumilli
    Adusumilli
  8. Hyman
    Hyman
  9. Perales
    Perales
  10. Solit
    Solit

Groups

  1. Department of Medicine (2037)
  2. GSK Faculty (1130)
  3. Solid Tumor Oncology Division (1105)
  4. Sloan Kettering Institute Postdocs (1022)
  5. Surgery (893)
  6. Survivorship Research (780)
  7. Center for Hematologic Malignancies (764)
  8. Hematologic Malignancies, Division of (714)
  9. Department of Pathology and Laboratory Medicine (653)
  10. Population Sciences Research Program (632)
  1. "2017"
Formats
  1. Journal Article (3053)
  2. Meeting Abstract (1581)
  3. Book Section (242)
  4. Conference Paper (35)
  5. Book Whole (12)
  6. Editorial (1)
  7. Review (1)
Groups
  1. Department of Medicine (2037)
  2. GSK Faculty (1130)
  3. Solid Tumor Oncology Division (1105)
  4. Sloan Kettering Institute Postdocs (1022)
  5. Surgery (893)
  6. Survivorship Research (780)

More Groups

People
  1. Sergio Giralt (86)
  2. Jose Baselga (68)
  3. Michael Berger (67)
  4. Monica Morrow (65)
  5. Jedd Wolchok (62)
  6. Martin Tallman (61)

More People

Years
  1. 2017 (4925)
Publications
  1. Journal of Clinical Oncology (349)
  2. Blood (233)
  3. Annals of Oncology (123)
  4. International Journal of Radiation Oncology, Biology, Physics (122)
  5. Modern Pathology (85)
  6. Laboratory Investigation (76)

More Publications

Publishers
  1. Elsevier Inc. (599)
  2. Springer (383)
  3. American Society of Clinical Oncology (378)
  4. Nature Publishing Group (310)
  5. Oxford University Press (280)
  6. American Society of Hematology (246)

More Publishers

Results (4925)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • WT1 heteroclitic epitope immunization following autologous stem cell transplantation in patients with high-risk multiple myeloma (MM)
    Meeting Abstract

    Koehne, G.; Devlin, S.; Chung, D.; Landau, H.; Korde, N.; Mailankody, S.; Hassoun, H.; Lesokhin, A.; Lendvai, N.; Giralt, S.; more...
    Haematologica (2017)

    Fulltext@MSK | Save
  • The dual SYK/JAK inhibitor cerdulatinib demonstrates complete inhibition of SYK and JAK and rapid tumor responses in a phase 2 study in patients with relapsed/refractory B cell malignancies
    Meeting Abstract

    Hamlin, P.; Farber, C.; Fenske, T.; Khatcheressian, J.; Miller, C.; Munoz, J.; Patel, M.; Smith, S.; Stevens, D.; Pandey, A.; more...
    Haematologica (2017)

    Fulltext@MSK | Save
  • Multiple myeloma and comorbidity: A population-based study
    Meeting Abstract

    Sverrisdottir, I. S.; Rögnvaldsson, S.; Lund, S. H.; Turesson, I.; Hultcrantz, M.; Björkholm, M.; Landgren, O.; Kristinsson, S. Y.
    Haematologica (2017)

    Fulltext@MSK | Save
  • Variant FLT3 mutations can be eradicated by cytarabine/anthracycline/crenolanib induction in adult patients with newly diagnosed FLT3 (ITK/TKD) mutant AML
    Meeting Abstract

    Wang, E.; Stone, R.; Collins, R.; Agrawal, T.; Urity, V.; Tallman, M.
    Haematologica (2017)

    Fulltext@MSK | Save
  • Patients with acute myeloid leukemia who have mutations in IDH1 or IDH2 respond well to induction chemotherapy with "7+3" despite the presence of complex karyotype or FLT3-ITD
    Meeting Abstract

    Gupta, D. M.; Devlin, D. S.; Tallman, D. M.; Stein, D. E.
    Haematologica (2017)

    Fulltext@MSK | Save
  • Venetoclax (VEN) in patients with relapsed/refractory non-Hodgkin lymphoma (NHL)
    Meeting Abstract

    Davids, M. S.; Roberts, A. W.; Seymour, J. F.; Wierda, W. G.; Puvvada, S. D.; Gressick, L.; Alter, D.; Zhou, L.; Kim, S. Y.; Verdugo, M.; more...
    Haematologica (2017)

    Fulltext@MSK | Save
  • Timing of defibrotide initiation post-diagnosis of hepatic veno-occlusive disease/sinusoidal obstruction syndrome after primary chemotherapy: Exploratory analysis of an expanded-access protocol
    Meeting Abstract

    Kernan, N.; Richardson, P.; Triplett, B.; Grupp, S.; Antin, J.; Liang, W.; Hume, R.; Tappe, W.; Soiffer, R.
    Haematologica (2017)

    Fulltext@MSK | Save
  • Defibrotide efficacy and safety in patients with hepatic veno-occlusive disease/sinusoidal obstruction syndrome (VOD/SOS) diagnosed after day 21: Analysis of final data from an expanded-access program
    Meeting Abstract

    Richardson, P.; Smith, A.; Triplett, B.; Kernan, N.; Grupp, S.; Antin, J.; Lehmann, L.; Giralt, S.; Ryan, R.; Hume, R.; more...
    Haematologica (2017)

    Fulltext@MSK | Save
  • Efficacy and safety of defibrotide in the treatment of hepatic veno-occlusive disease/sinusoidal obstruction syndrome following hematopoietic stem cell transplantation: Final subgroup results
    Meeting Abstract

    Richardson, P.; Smith, A.; Triplett, B.; Kernan, N.; Grupp, S.; Antin, J.; Lehmann, L.; Giralt, S.; Liang, W.; Hume, R.; more...
    Haematologica (2017)

    Fulltext@MSK | Save
  • Durable long-term survival of adult patients with B-ALL after CD19 CAR (19-28z) T cell therapy
    Meeting Abstract

    Park, J.; Riviere, I.; Wang, X.; Senechal, B.; Wang, Y.; Purdon, T.; Brentjens, R.; Sadelain, M.
    Haematologica (2017)

    Fulltext@MSK | Save